ICUIICU Medical, Inc.

Healthcare

$160.40+22% 1Y

$160.40

$114.1352 weeks$187.34

Price

+22%1Y

End-of-day closes, not the intraday tick.

Great business, demanding price

Quality strong, no red flags, demanding price, growth fading, the market undecided.

RyuScore 22 of 100: see how it is built

What they do

We offer a broad range of anesthesia systems and devices and breathing circuits, ventilation, respiratory and specialty airway products that maintain patients’ airways before, during and after surgery. Our primary Anesthesia & Respiratory products are: Temperature Management solutions systems are used in perioperative and critical care settings to help monitor and regulate patient temperature. Our primary Temperature Management products include:

In the company’s own words · 10-K filed Feb 19, 2026 · SEC EDGAR

P/E134.8

Market value$3.72B

1 year+22%

5 years-33%

Charts

As reported to the SEC, without any scoring.

ICU Medical, Inc. (ICUI) reported revenue of $552M in Q2 2026 (quarter ended Jun 30, 2026), up 0.5% from the same quarter a year earlier. That came with a gross margin of 43% and net income of $19M (3.5% of revenue). For the full year FY2025, revenue was $2.23B (−6.3% year on year) and net income $732K. Its largest product in Q2 2026 was Infusion Consumables at $289M, 52% of the disclosed total, ahead of Infusion Systems at 34%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.

What the company said

The company's own words from its current reports to the SEC, newest first

Aug 6, 2026ICU Medical Announces Second Quarter 2026 Results.Earnings release · press release
May 18, 2026On May 13, 2026, ICU Medical, Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”)Charter/bylaw amendment or fiscal-year change · Form 8-K
May 7, 2026ICU Medical Announces First Quarter 2026 Results.Earnings release · press release